Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016, Article ID 7217915, 3 pages
http://dx.doi.org/10.1155/2016/7217915
Case Report

Massive Bleeding as the First Clinical Manifestation of Metastatic Prostate Cancer due to Disseminated Intravascular Coagulation with Enhanced Fibrinolysis

1Internal Medicine Department 2, Hospital de Santa Maria, Lisboa, Portugal
2Faculdade de Medicina de Lisboa, Lisboa, Portugal

Received 7 July 2016; Revised 3 September 2016; Accepted 8 September 2016

Academic Editor: Yusuke Shiozawa

Copyright © 2016 Mónica Palma Anselmo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. B. Taylor Jr., C. H. Toh, W. K. Hoots, H. Wada, and M. Levi, “Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation,” Thrombosis and Haemostasis, vol. 86, pp. 1327–1330, 2001. View at Google Scholar
  2. H. Asakura, “Classifying types of disseminated intravascular coagulation: clinical and animal models,” Journal of Intensive Care, vol. 2, no. 1, p. 20, 2014. View at Publisher · View at Google Scholar
  3. A. A. Salako, O. A. Arowolo, E. A. Omonisi, A. O. Adisa, N. A. Titiloye, and K. Adelusola, “Incidental carcinoma of the prostate gland presenting with initial manifestation of disseminated intravascular coagulopathy (dic) in a middle aged man: a case report,” Cases Journal, vol. 2, no. 9, article 144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Wada, T. Matsumoto, and Y. Yamashita, “Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines,” Journal of Intensive Care, vol. 2, article 15, 2014. View at Publisher · View at Google Scholar
  5. H. Wada, J. Thachil, M. Di Nisio et al., “Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines,” Journal of Thrombosis and Haemostasis, vol. 11, no. 4, pp. 761–767, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Thachil, A. Falanga, M. Levi, H. Liebman, and M. Di Nisio, “Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH,” Journal of Thrombosis and Haemostasis, vol. 13, no. 4, pp. 671–675, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Fouchardière, A. Flechon, and J.-P. Droz, “Coagulopathy in prostate cancer,” The Netherlands Journal of Medicine, vol. 61, no. 11, pp. 347–354, 2003. View at Google Scholar
  8. D. M. Hyman, G. A. Soff, and L. J. Kampel, “Disseminated intravascular coagulation with excessive fibrinolysis in prostate cancer: a case series and review of the literature,” Oncology, vol. 81, no. 2, pp. 119–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Duran and I. F. Tannock, “Disseminated intravascular coagulation as the presenting sign of metastatic prostate cancer,” Journal of General Internal Medicine, vol. 21, no. 11, pp. C6–C8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Bern, “Coagulopathy, following medical therapy, for carcinoma of the prostate,” Hematology, vol. 10, no. 1, pp. 65–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Navarro, I. Ruiz, G. Martín, and J. J. Cruz, “Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy,” Prostate Cancer and Prostatic Diseases, vol. 9, no. 2, pp. 190–191, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Wada, M. Uchiba, Y. Kawano et al., “Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report,” Journal of Medical Case Reports, vol. 6, article 378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. J. Kampel, “Challenging problems in advanced malignancy. Case 2. Disseminated intravascular coagulation in metastatic hormone-refractory prostate cancer,” Journal of Clinical Oncology, vol. 21, no. 16, pp. 3170–3171, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Labelle and C. S. Kitchens, “Disseminated intravascular coagulation: treat the cause, not the lab values,” Cleveland Clinic Journal of Medicine, vol. 72, no. 5, pp. 377–397, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. C. H. Toh and Y. Alhamdi, “Current consideration and management of disseminated intravascular coagulation,” American Society of Hematology, vol. 1, pp. 286–291, 2013. View at Google Scholar
  16. M. Levi, C. H. Toh, J. Thachil, and H. G. Watson, “Guidelines for the diagnosis and management of disseminated intravascular coagulation,” British Journal of Haematology, vol. 145, no. 1, pp. 24–33, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Wada, H. Asakura, K. Okamoto et al., “Expert consensus for the treatment of disseminated intravascular coagulation in Japan,” Thrombosis Research, vol. 125, no. 1, pp. 6–11, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Di Nisio, F. Baudo, B. Cosmi et al., “Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian society for haemostasis and thrombosis (SISET),” Thrombosis Research, vol. 129, no. 5, pp. e177–e184, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Brown, A. Olujohungbe, J. Chang et al., “All-trans retinoic acid (ATRA) and tranexamic acid: a potentially fatal combination in acute promyelocytic leukaemia,” British Journal of Haematology, vol. 110, no. 4, pp. 1010–1012, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. D. L. Cooper, A. B. Sandler, L. D. Wilson, and T. P. Duffy, “Disseminated intravascular coagulation and excessive fibrinolysis in a patient with metastatic prostate cancer. Response to epsilon-aminocaproic acid,” Cancer, vol. 70, no. 3, pp. 656–658, 1992. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Ohtake, S. Kurita, Y. Fukabori et al., “Clinical study on prostate cancer initially presenting with disseminated intravascular coagulation syndrome,” Acta Urologica Japonica, vol. 44, no. 6, pp. 387–390, 1998. View at Google Scholar · View at Scopus
  22. A. Sawamura, M. Hayakawa, S. Gando et al., “Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality,” Thrombosis Research, vol. 124, no. 5, pp. 608–613, 2009. View at Publisher · View at Google Scholar · View at Scopus